Turkey · Delayed Price · Currency is TRY IST:BIOEN Statistics
Total Valuation
IST:BIOEN has a market cap or net worth of TRY 11.11 billion. The enterprise value is 15.83 billion.
| Market Cap | 11.11B |
| Enterprise Value | 15.83B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:BIOEN has 500.00 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 500.00M |
| Shares Outstanding | 500.00M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 21.65% |
| Float | 227.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.71 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 3.06 |
| P/FCF Ratio | 11.43 |
| P/OCF Ratio | 7.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 51.58, with an EV/FCF ratio of 16.29.
| EV / Earnings | -29.05 |
| EV / Sales | 6.71 |
| EV / EBITDA | 51.58 |
| EV / EBIT | n/a |
| EV / FCF | 16.29 |
Financial Position
The company has a current ratio of 0.53, with a Debt / Equity ratio of 1.15.
| Current Ratio | 0.53 |
| Quick Ratio | 0.16 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 13.98 |
| Debt / FCF | 4.91 |
| Interest Coverage | -1.04 |
Financial Efficiency
Return on equity (ROE) is -14.24% and return on invested capital (ROIC) is -2.84%.
| Return on Equity (ROE) | -14.24% |
| Return on Assets (ROA) | -2.61% |
| Return on Invested Capital (ROIC) | -2.84% |
| Return on Capital Employed (ROCE) | -4.66% |
| Revenue Per Employee | 3.27M |
| Profits Per Employee | -756,763 |
| Employee Count | 717 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 6.45 |
Taxes
| Income Tax | -131.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.18% in the last 52 weeks. The beta is 0.07, so IST:BIOEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | +24.18% |
| 50-Day Moving Average | 24.45 |
| 200-Day Moving Average | 20.51 |
| Relative Strength Index (RSI) | 37.62 |
| Average Volume (20 Days) | 2,340,402 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:BIOEN had revenue of TRY 2.36 billion and -544.87 million in losses. Loss per share was -1.09.
| Revenue | 2.36B |
| Gross Profit | 68.60M |
| Operating Income | -371.99M |
| Pretax Income | -681.98M |
| Net Income | -544.87M |
| EBITDA | 248.74M |
| EBIT | -371.99M |
| Loss Per Share | -1.09 |
Balance Sheet
The company has 53.16 million in cash and 4.77 billion in debt, giving a net cash position of -4.72 billion or -9.44 per share.
| Cash & Cash Equivalents | 53.16M |
| Total Debt | 4.77B |
| Net Cash | -4.72B |
| Net Cash Per Share | -9.44 |
| Equity (Book Value) | 4.15B |
| Book Value Per Share | 8.29 |
| Working Capital | -865.27M |
Cash Flow
In the last 12 months, operating cash flow was 1.52 billion and capital expenditures -546.46 million, giving a free cash flow of 971.78 million.
| Operating Cash Flow | 1.52B |
| Capital Expenditures | -546.46M |
| Free Cash Flow | 971.78M |
| FCF Per Share | 1.94 |
Margins
Gross margin is 2.91%, with operating and profit margins of -15.78% and -23.11%.
| Gross Margin | 2.91% |
| Operating Margin | -15.78% |
| Pretax Margin | -28.93% |
| Profit Margin | -23.11% |
| EBITDA Margin | 10.55% |
| EBIT Margin | -15.78% |
| FCF Margin | 41.22% |
Dividends & Yields
IST:BIOEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.17% |
| Earnings Yield | -4.90% |
| FCF Yield | 8.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 24, 2021. It was a forward split with a ratio of 3.3333333.
| Last Split Date | Nov 24, 2021 |
| Split Type | Forward |
| Split Ratio | 3.3333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |